aluates Reports

$ 0.0

Automative

Global Therapeutic Antibody Discovery Platform Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-4A13249

Global Therapeutic Antibody Discovery Platform Market Research Report 2023

BUY CHAPTERS

Global Therapeutic Antibody Discovery Platform Market Research Report 2025

Code: QYRE-Auto-4A13249

Report

April 2025

Pages:99

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

YUMAB

Ablexis

AvantGen

OXGENE

Evotec AG

Charles River Laboratories

Chugai Pharmaceutical

AbCellera

Twist Bioscience

Bio Rad

Antibody Solutions

Lepu Biopharma

Abveris

Alacrita

Invetx

Aerium Therapeutics

Talem Therapeutics

Memo Therapeutics

OmniAb

Therapeutic Antibody Discovery Platform Market Size

The global market for Therapeutic Antibody Discovery Platform was valued at US$ 946 million in the year 2024 and is projected to reach a revised size of US$ 1803 million by 2031, growing at a CAGR of 9.8% during the forecast period.

Therapeutic Antibody Discovery Platform Market

Antibody discovery platforms have emerged in recent years as an important source of both therapeutic molecules and research reagents.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Therapeutic Antibody Discovery Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Antibody Discovery Platform.

The Therapeutic Antibody Discovery Platform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Antibody Discovery Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Therapeutic Antibody Discovery Platform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Therapeutic Antibody Discovery Platform Market Report

Report Metric	Details
Report Name	Therapeutic Antibody Discovery Platform Market
Accounted market size in year	US$ 946 million
Forecasted market size in 2031	US$ 1803 million
CAGR	9.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Animal Human
Segment by Application	Pharmaceutical and Biotechnology Companies Research Laboratories
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abveris, YUMAB, Ablexis, AvantGen, OXGENE, Evotec, Alacrita, Invetx, Charles River Laboratories, Aerium Therapeutics, Chugai Pharmaceutical, AbCellera, Twist Bioscience, Talem Therapeutics, Bio-Rad, Memo Therapeutics, OmniAb, Antibody Solutions, Lepu Biopharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapeutic Antibody Discovery Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Therapeutic Antibody Discovery Platform Market growing?

Ans: The Therapeutic Antibody Discovery Platform Market witnessing a CAGR of 9.8% during the forecast period 2025-2031.

What is the Therapeutic Antibody Discovery Platform Market size in 2031?

Ans: The Therapeutic Antibody Discovery Platform Market size in 2031 will be US$ 1803 million.

Who are the main players in the Therapeutic Antibody Discovery Platform Market report?

Ans: The main players in the Therapeutic Antibody Discovery Platform Market are Abveris, YUMAB, Ablexis, AvantGen, OXGENE, Evotec, Alacrita, Invetx, Charles River Laboratories, Aerium Therapeutics, Chugai Pharmaceutical, AbCellera, Twist Bioscience, Talem Therapeutics, Bio-Rad, Memo Therapeutics, OmniAb, Antibody Solutions, Lepu Biopharma

What are the Application segmentation covered in the Therapeutic Antibody Discovery Platform Market report?

Ans: The Applications covered in the Therapeutic Antibody Discovery Platform Market report are Pharmaceutical and Biotechnology Companies, Research Laboratories

What are the Type segmentation covered in the Therapeutic Antibody Discovery Platform Market report?

Ans: The Types covered in the Therapeutic Antibody Discovery Platform Market report are Animal, Human

Recommended Reports

Antibody Platforms

Immunology Diagnostics

Autoimmune Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Therapeutic Antibody Discovery Platform Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Animal

1.2.3 Human

1.3 Market by Application

1.3.1 Global Therapeutic Antibody Discovery Platform Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical and Biotechnology Companies

1.3.3 Research Laboratories

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Therapeutic Antibody Discovery Platform Market Perspective (2020-2031)

2.2 Global Therapeutic Antibody Discovery Platform Growth Trends by Region

2.2.1 Global Therapeutic Antibody Discovery Platform Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Therapeutic Antibody Discovery Platform Historic Market Size by Region (2020-2025)

2.2.3 Therapeutic Antibody Discovery Platform Forecasted Market Size by Region (2026-2031)

2.3 Therapeutic Antibody Discovery Platform Market Dynamics

2.3.1 Therapeutic Antibody Discovery Platform Industry Trends

2.3.2 Therapeutic Antibody Discovery Platform Market Drivers

2.3.3 Therapeutic Antibody Discovery Platform Market Challenges

2.3.4 Therapeutic Antibody Discovery Platform Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Therapeutic Antibody Discovery Platform Players by Revenue

3.1.1 Global Top Therapeutic Antibody Discovery Platform Players by Revenue (2020-2025)

3.1.2 Global Therapeutic Antibody Discovery Platform Revenue Market Share by Players (2020-2025)

3.2 Global Therapeutic Antibody Discovery Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Therapeutic Antibody Discovery Platform Revenue

3.4 Global Therapeutic Antibody Discovery Platform Market Concentration Ratio

3.4.1 Global Therapeutic Antibody Discovery Platform Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Antibody Discovery Platform Revenue in 2024

3.5 Global Key Players of Therapeutic Antibody Discovery Platform Head office and Area Served

3.6 Global Key Players of Therapeutic Antibody Discovery Platform, Product and Application

3.7 Global Key Players of Therapeutic Antibody Discovery Platform, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Therapeutic Antibody Discovery Platform Breakdown Data by Type

4.1 Global Therapeutic Antibody Discovery Platform Historic Market Size by Type (2020-2025)

4.2 Global Therapeutic Antibody Discovery Platform Forecasted Market Size by Type (2026-2031)

5 Therapeutic Antibody Discovery Platform Breakdown Data by Application

5.1 Global Therapeutic Antibody Discovery Platform Historic Market Size by Application (2020-2025)

5.2 Global Therapeutic Antibody Discovery Platform Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Therapeutic Antibody Discovery Platform Market Size (2020-2031)

6.2 North America Therapeutic Antibody Discovery Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Therapeutic Antibody Discovery Platform Market Size by Country (2020-2025)

6.4 North America Therapeutic Antibody Discovery Platform Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Therapeutic Antibody Discovery Platform Market Size (2020-2031)

7.2 Europe Therapeutic Antibody Discovery Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Therapeutic Antibody Discovery Platform Market Size by Country (2020-2025)

7.4 Europe Therapeutic Antibody Discovery Platform Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Therapeutic Antibody Discovery Platform Market Size (2020-2031)

8.2 Asia-Pacific Therapeutic Antibody Discovery Platform Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Therapeutic Antibody Discovery Platform Market Size by Region (2020-2025)

8.4 Asia-Pacific Therapeutic Antibody Discovery Platform Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Therapeutic Antibody Discovery Platform Market Size (2020-2031)

9.2 Latin America Therapeutic Antibody Discovery Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Therapeutic Antibody Discovery Platform Market Size by Country (2020-2025)

9.4 Latin America Therapeutic Antibody Discovery Platform Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Therapeutic Antibody Discovery Platform Market Size (2020-2031)

10.2 Middle East & Africa Therapeutic Antibody Discovery Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Therapeutic Antibody Discovery Platform Market Size by Country (2020-2025)

10.4 Middle East & Africa Therapeutic Antibody Discovery Platform Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abveris

11.1.1 Abveris Company Details

11.1.2 Abveris Business Overview

11.1.3 Abveris Therapeutic Antibody Discovery Platform Introduction

11.1.4 Abveris Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.1.5 Abveris Recent Development

11.2 YUMAB

11.2.1 YUMAB Company Details

11.2.2 YUMAB Business Overview

11.2.3 YUMAB Therapeutic Antibody Discovery Platform Introduction

11.2.4 YUMAB Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.2.5 YUMAB Recent Development

11.3 Ablexis

11.3.1 Ablexis Company Details

11.3.2 Ablexis Business Overview

11.3.3 Ablexis Therapeutic Antibody Discovery Platform Introduction

11.3.4 Ablexis Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.3.5 Ablexis Recent Development

11.4 AvantGen

11.4.1 AvantGen Company Details

11.4.2 AvantGen Business Overview

11.4.3 AvantGen Therapeutic Antibody Discovery Platform Introduction

11.4.4 AvantGen Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.4.5 AvantGen Recent Development

11.5 OXGENE

11.5.1 OXGENE Company Details

11.5.2 OXGENE Business Overview

11.5.3 OXGENE Therapeutic Antibody Discovery Platform Introduction

11.5.4 OXGENE Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.5.5 OXGENE Recent Development

11.6 Evotec

11.6.1 Evotec Company Details

11.6.2 Evotec Business Overview

11.6.3 Evotec Therapeutic Antibody Discovery Platform Introduction

11.6.4 Evotec Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.6.5 Evotec Recent Development

11.7 Alacrita

11.7.1 Alacrita Company Details

11.7.2 Alacrita Business Overview

11.7.3 Alacrita Therapeutic Antibody Discovery Platform Introduction

11.7.4 Alacrita Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.7.5 Alacrita Recent Development

11.8 Invetx

11.8.1 Invetx Company Details

11.8.2 Invetx Business Overview

11.8.3 Invetx Therapeutic Antibody Discovery Platform Introduction

11.8.4 Invetx Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.8.5 Invetx Recent Development

11.9 Charles River Laboratories

11.9.1 Charles River Laboratories Company Details

11.9.2 Charles River Laboratories Business Overview

11.9.3 Charles River Laboratories Therapeutic Antibody Discovery Platform Introduction

11.9.4 Charles River Laboratories Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.9.5 Charles River Laboratories Recent Development

11.10 Aerium Therapeutics

11.10.1 Aerium Therapeutics Company Details

11.10.2 Aerium Therapeutics Business Overview

11.10.3 Aerium Therapeutics Therapeutic Antibody Discovery Platform Introduction

11.10.4 Aerium Therapeutics Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.10.5 Aerium Therapeutics Recent Development

11.11 Chugai Pharmaceutical

11.11.1 Chugai Pharmaceutical Company Details

11.11.2 Chugai Pharmaceutical Business Overview

11.11.3 Chugai Pharmaceutical Therapeutic Antibody Discovery Platform Introduction

11.11.4 Chugai Pharmaceutical Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.11.5 Chugai Pharmaceutical Recent Development

11.12 AbCellera

11.12.1 AbCellera Company Details

11.12.2 AbCellera Business Overview

11.12.3 AbCellera Therapeutic Antibody Discovery Platform Introduction

11.12.4 AbCellera Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.12.5 AbCellera Recent Development

11.13 Twist Bioscience

11.13.1 Twist Bioscience Company Details

11.13.2 Twist Bioscience Business Overview

11.13.3 Twist Bioscience Therapeutic Antibody Discovery Platform Introduction

11.13.4 Twist Bioscience Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.13.5 Twist Bioscience Recent Development

11.14 Talem Therapeutics

11.14.1 Talem Therapeutics Company Details

11.14.2 Talem Therapeutics Business Overview

11.14.3 Talem Therapeutics Therapeutic Antibody Discovery Platform Introduction

11.14.4 Talem Therapeutics Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.14.5 Talem Therapeutics Recent Development

11.15 Bio-Rad

11.15.1 Bio-Rad Company Details

11.15.2 Bio-Rad Business Overview

11.15.3 Bio-Rad Therapeutic Antibody Discovery Platform Introduction

11.15.4 Bio-Rad Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.15.5 Bio-Rad Recent Development

11.16 Memo Therapeutics

11.16.1 Memo Therapeutics Company Details

11.16.2 Memo Therapeutics Business Overview

11.16.3 Memo Therapeutics Therapeutic Antibody Discovery Platform Introduction

11.16.4 Memo Therapeutics Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.16.5 Memo Therapeutics Recent Development

11.17 OmniAb

11.17.1 OmniAb Company Details

11.17.2 OmniAb Business Overview

11.17.3 OmniAb Therapeutic Antibody Discovery Platform Introduction

11.17.4 OmniAb Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.17.5 OmniAb Recent Development

11.18 Antibody Solutions

11.18.1 Antibody Solutions Company Details

11.18.2 Antibody Solutions Business Overview

11.18.3 Antibody Solutions Therapeutic Antibody Discovery Platform Introduction

11.18.4 Antibody Solutions Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.18.5 Antibody Solutions Recent Development

11.19 Lepu Biopharma

11.19.1 Lepu Biopharma Company Details

11.19.2 Lepu Biopharma Business Overview

11.19.3 Lepu Biopharma Therapeutic Antibody Discovery Platform Introduction

11.19.4 Lepu Biopharma Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025)

11.19.5 Lepu Biopharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

YUMAB

Ablexis

AvantGen

OXGENE

Evotec AG

Charles River Laboratories

Chugai Pharmaceutical

AbCellera

Twist Bioscience

Bio Rad

Antibody Solutions

Lepu Biopharma

Abveris

Alacrita

Invetx

Aerium Therapeutics

Talem Therapeutics

Memo Therapeutics

OmniAb

List of Tables

Table 1. Global Therapeutic Antibody Discovery Platform Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Animal

Table 3. Key Players of Human

Table 4. Global Therapeutic Antibody Discovery Platform Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Therapeutic Antibody Discovery Platform Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Therapeutic Antibody Discovery Platform Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Therapeutic Antibody Discovery Platform Market Share by Region (2020-2025)

Table 8. Global Therapeutic Antibody Discovery Platform Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Therapeutic Antibody Discovery Platform Market Share by Region (2026-2031)

Table 10. Therapeutic Antibody Discovery Platform Market Trends

Table 11. Therapeutic Antibody Discovery Platform Market Drivers

Table 12. Therapeutic Antibody Discovery Platform Market Challenges

Table 13. Therapeutic Antibody Discovery Platform Market Restraints

Table 14. Global Therapeutic Antibody Discovery Platform Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Therapeutic Antibody Discovery Platform Market Share by Players (2020-2025)

Table 16. Global Top Therapeutic Antibody Discovery Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Antibody Discovery Platform as of 2024)

Table 17. Ranking of Global Top Therapeutic Antibody Discovery Platform Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Therapeutic Antibody Discovery Platform Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Therapeutic Antibody Discovery Platform, Headquarters and Area Served

Table 20. Global Key Players of Therapeutic Antibody Discovery Platform, Product and Application

Table 21. Global Key Players of Therapeutic Antibody Discovery Platform, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Therapeutic Antibody Discovery Platform Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Therapeutic Antibody Discovery Platform Revenue Market Share by Type (2020-2025)

Table 25. Global Therapeutic Antibody Discovery Platform Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Therapeutic Antibody Discovery Platform Revenue Market Share by Type (2026-2031)

Table 27. Global Therapeutic Antibody Discovery Platform Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Therapeutic Antibody Discovery Platform Revenue Market Share by Application (2020-2025)

Table 29. Global Therapeutic Antibody Discovery Platform Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Therapeutic Antibody Discovery Platform Revenue Market Share by Application (2026-2031)

Table 31. North America Therapeutic Antibody Discovery Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Therapeutic Antibody Discovery Platform Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Therapeutic Antibody Discovery Platform Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Therapeutic Antibody Discovery Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Therapeutic Antibody Discovery Platform Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Therapeutic Antibody Discovery Platform Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Therapeutic Antibody Discovery Platform Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Therapeutic Antibody Discovery Platform Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Therapeutic Antibody Discovery Platform Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Therapeutic Antibody Discovery Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Therapeutic Antibody Discovery Platform Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Therapeutic Antibody Discovery Platform Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Therapeutic Antibody Discovery Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Therapeutic Antibody Discovery Platform Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Therapeutic Antibody Discovery Platform Market Size by Country (2026-2031) & (US$ Million)

Table 46. Abveris Company Details

Table 47. Abveris Business Overview

Table 48. Abveris Therapeutic Antibody Discovery Platform Product

Table 49. Abveris Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 50. Abveris Recent Development

Table 51. YUMAB Company Details

Table 52. YUMAB Business Overview

Table 53. YUMAB Therapeutic Antibody Discovery Platform Product

Table 54. YUMAB Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 55. YUMAB Recent Development

Table 56. Ablexis Company Details

Table 57. Ablexis Business Overview

Table 58. Ablexis Therapeutic Antibody Discovery Platform Product

Table 59. Ablexis Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 60. Ablexis Recent Development

Table 61. AvantGen Company Details

Table 62. AvantGen Business Overview

Table 63. AvantGen Therapeutic Antibody Discovery Platform Product

Table 64. AvantGen Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 65. AvantGen Recent Development

Table 66. OXGENE Company Details

Table 67. OXGENE Business Overview

Table 68. OXGENE Therapeutic Antibody Discovery Platform Product

Table 69. OXGENE Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 70. OXGENE Recent Development

Table 71. Evotec Company Details

Table 72. Evotec Business Overview

Table 73. Evotec Therapeutic Antibody Discovery Platform Product

Table 74. Evotec Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 75. Evotec Recent Development

Table 76. Alacrita Company Details

Table 77. Alacrita Business Overview

Table 78. Alacrita Therapeutic Antibody Discovery Platform Product

Table 79. Alacrita Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 80. Alacrita Recent Development

Table 81. Invetx Company Details

Table 82. Invetx Business Overview

Table 83. Invetx Therapeutic Antibody Discovery Platform Product

Table 84. Invetx Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 85. Invetx Recent Development

Table 86. Charles River Laboratories Company Details

Table 87. Charles River Laboratories Business Overview

Table 88. Charles River Laboratories Therapeutic Antibody Discovery Platform Product

Table 89. Charles River Laboratories Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 90. Charles River Laboratories Recent Development

Table 91. Aerium Therapeutics Company Details

Table 92. Aerium Therapeutics Business Overview

Table 93. Aerium Therapeutics Therapeutic Antibody Discovery Platform Product

Table 94. Aerium Therapeutics Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 95. Aerium Therapeutics Recent Development

Table 96. Chugai Pharmaceutical Company Details

Table 97. Chugai Pharmaceutical Business Overview

Table 98. Chugai Pharmaceutical Therapeutic Antibody Discovery Platform Product

Table 99. Chugai Pharmaceutical Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 100. Chugai Pharmaceutical Recent Development

Table 101. AbCellera Company Details

Table 102. AbCellera Business Overview

Table 103. AbCellera Therapeutic Antibody Discovery Platform Product

Table 104. AbCellera Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 105. AbCellera Recent Development

Table 106. Twist Bioscience Company Details

Table 107. Twist Bioscience Business Overview

Table 108. Twist Bioscience Therapeutic Antibody Discovery Platform Product

Table 109. Twist Bioscience Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 110. Twist Bioscience Recent Development

Table 111. Talem Therapeutics Company Details

Table 112. Talem Therapeutics Business Overview

Table 113. Talem Therapeutics Therapeutic Antibody Discovery Platform Product

Table 114. Talem Therapeutics Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 115. Talem Therapeutics Recent Development

Table 116. Bio-Rad Company Details

Table 117. Bio-Rad Business Overview

Table 118. Bio-Rad Therapeutic Antibody Discovery Platform Product

Table 119. Bio-Rad Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 120. Bio-Rad Recent Development

Table 121. Memo Therapeutics Company Details

Table 122. Memo Therapeutics Business Overview

Table 123. Memo Therapeutics Therapeutic Antibody Discovery Platform Product

Table 124. Memo Therapeutics Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 125. Memo Therapeutics Recent Development

Table 126. OmniAb Company Details

Table 127. OmniAb Business Overview

Table 128. OmniAb Therapeutic Antibody Discovery Platform Product

Table 129. OmniAb Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 130. OmniAb Recent Development

Table 131. Antibody Solutions Company Details

Table 132. Antibody Solutions Business Overview

Table 133. Antibody Solutions Therapeutic Antibody Discovery Platform Product

Table 134. Antibody Solutions Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 135. Antibody Solutions Recent Development

Table 136. Lepu Biopharma Company Details

Table 137. Lepu Biopharma Business Overview

Table 138. Lepu Biopharma Therapeutic Antibody Discovery Platform Product

Table 139. Lepu Biopharma Revenue in Therapeutic Antibody Discovery Platform Business (2020-2025) & (US$ Million)

Table 140. Lepu Biopharma Recent Development

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

Table 144. Authors List of This Report

List of Figures

Figure 1. Therapeutic Antibody Discovery Platform Picture

Figure 2. Global Therapeutic Antibody Discovery Platform Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Therapeutic Antibody Discovery Platform Market Share by Type: 2024 VS 2031

Figure 4. Animal Features

Figure 5. Human Features

Figure 6. Global Therapeutic Antibody Discovery Platform Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Therapeutic Antibody Discovery Platform Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceutical and Biotechnology Companies Case Studies

Figure 9. Research Laboratories Case Studies

Figure 10. Therapeutic Antibody Discovery Platform Report Years Considered

Figure 11. Global Therapeutic Antibody Discovery Platform Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Therapeutic Antibody Discovery Platform Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Therapeutic Antibody Discovery Platform Market Share by Region: 2024 VS 2031

Figure 14. Global Therapeutic Antibody Discovery Platform Market Share by Players in 2024

Figure 15. Global Top Therapeutic Antibody Discovery Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Antibody Discovery Platform as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Therapeutic Antibody Discovery Platform Revenue in 2024

Figure 17. North America Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Therapeutic Antibody Discovery Platform Market Share by Country (2020-2031)

Figure 19. United States Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Therapeutic Antibody Discovery Platform Market Share by Country (2020-2031)

Figure 23. Germany Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Therapeutic Antibody Discovery Platform Market Share by Region (2020-2031)

Figure 31. China Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Therapeutic Antibody Discovery Platform Market Share by Country (2020-2031)

Figure 39. Mexico Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Therapeutic Antibody Discovery Platform Market Share by Country (2020-2031)

Figure 43. Turkey Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Therapeutic Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Abveris Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 47. YUMAB Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 48. Ablexis Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 49. AvantGen Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 50. OXGENE Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 51. Evotec Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 52. Alacrita Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 53. Invetx Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 54. Charles River Laboratories Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 55. Aerium Therapeutics Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 56. Chugai Pharmaceutical Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 57. AbCellera Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 58. Twist Bioscience Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 59. Talem Therapeutics Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 60. Bio-Rad Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 61. Memo Therapeutics Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 62. OmniAb Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 63. Antibody Solutions Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 64. Lepu Biopharma Revenue Growth Rate in Therapeutic Antibody Discovery Platform Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Hybridoma Antibody Discovery Platform Market Research Report 2025

Global Antibody Based Therapeutics Market Research Report 2024

Global Therapeutic Antibodies Drug Market Research Report 2024

AI Drug Discovery Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Single Domain Antibody Platform Market Research Report 2024

Global AI based Antibody Development Platform Market Research Report 2024

Global Cloud Based Drug Discovery Platform Market Research Report 2024

Global Single Domain Antibody Platforms Market Research Report 2024

Global Multispecific Antibody Development Platform Market Research Report 2024

Global Antibody Discovery and Development Services Market Research Report 2024

Global Cloud Based Drug Discovery Platforms Market Research Report 2024

Global Clinical Grade Antibody Portfolio Market Research Report 2025

Antibody Drug Conjugate Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Digital Therapeutics Platforms Market Research Report 2024

Global Innovative Drug Commercialization Service Platform Market Research Report 2024

Global Double Antibody Technology Platform Market Research Report 2025

Global Research Area Antibodies Market Research Report 2025

Oligonucleotide Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Apps Discovery Platform Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions